Pharmacy Benefit Managers Are Again In The Crosshairs Of Congress And The FTC: Action To Reform Drug Pricing Increasingly Likely PBMs are again in the crosshairs of Congress and the FTC. This time, Congress is seeking ways to coordinate with the FTC to enact reforms. It’s becoming increasingly probable that some kind of action will be taken to create a more transparent drug pricing and rebate system.